Health Care [ 8/12 ] | Life Sciences Tools & Services [ 63/73 ]
NASDAQ | Common Stock
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.
Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.
It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products.
The company was founded in 2019 and is based in Naples, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 15, 25 | -19.86 Increased by +72.63% | - |
| Mar 28, 25 | -2.15 Increased by +90.62% | - |
| Sep 30, 24 | -111.20 Decreased by -2.32 K% | - |
| Jun 30, 24 | -109.33 Decreased by -32.50% | - |
| Mar 31, 24 | -72.55 Decreased by -248.63% | - |
| Dec 31, 23 | -22.91 Decreased by -76.47 K% | - |
| Sep 30, 23 | -4.60 Decreased by -46.14 K% | - |
| Jun 30, 23 | -82.52 Decreased by -825.07 K% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 624.86 M Increased by +16.65% | -5.15 M Decreased by -44.11% | Decreased by -0.82% Decreased by -23.54% |
| Dec 31, 24 | 1.08 B Increased by +N/A% | -2.41 M Decreased by -235.24% | Decreased by -0.22% Decreased by N/A% |
| Sep 30, 24 | 654.93 M Increased by +N/A% | -6.46 M Decreased by -425.33% | Decreased by -0.99% Decreased by N/A% |
| Jun 30, 24 | 604.34 M Increased by +N/A% | -5.38 M Decreased by -210.62% | Decreased by -0.89% Decreased by N/A% |
| Mar 31, 24 | 535.67 M Increased by +N/A% | -3.57 M Decreased by -113.58% | Decreased by -0.67% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | 1.78 M Increased by +157.93% | Increased by +N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | 1.99 M Increased by +307.74% | Increased by +N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -1.73 M Decreased by -1.37 K% | Decreased by N/A% - |